Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan
by Press Release from Outbreak News Today on (#56NTG)
Novavax, Inc., a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, and Takeda Pharmaceutical Company Limited, today announced a partnership for the development, manufacturing and commercialization of NVXCoV2373, Novavax' COVID19 vaccine candidate, in Japan. NVXCoV2373 is a stable, prefusion protein made using Novavax' recombinant protein nanoparticle technology and includes Novavax' proprietary MatrixMTM [...]
The post Novavax and Takeda Announce Collaboration for Novavax' COVID-19 Vaccine Candidate in Japan appeared first on Outbreak News Today.